News Lincoln Pharmaceuticals Limited NSE India S.E.

Equities

LINCOLN

INE405C01035

Market Closed - NSE India S.E. Other stock markets 07:40:48 2024-05-16 EDT			5-day change	1st Jan Change
572.8 ^INR	-4.63%		+0.39%	-6.03%

03-30	Lincoln Pharmaceuticals Limited Announces Pirabhai Suthar Will Cease to Be an Independent Director	CI
02-22	Lincoln Pharmaceuticals Limited Announces Resignation of Meha Patel as Non-Executive Independent women Director	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Lincoln Pharmaceuticals Limited Announces Pirabhai Suthar Will Cease to Be an Independent Director	03-30	CI
Lincoln Pharmaceuticals Limited Announces Resignation of Meha Patel as Non-Executive Independent women Director	02-22	CI
Lincoln Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02-08	CI
Lincoln Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	11-02	CI
Lincoln Pharmaceuticals Limited Declares Dividend for the Financial Year 2022-23	23-09-30	CI
Lincoln Pharmaceuticals Limited Proposes Dividend for the Financial Year 2022-2023	23-09-06	CI
Lincoln Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-10	CI
Lincoln Pharmaceuticals Limited Recommends A Dividend for the Year Ended March 31, 2023	23-05-25	CI
Lincoln Pharmaceuticals Limited Approves the Resignation of Anand A. Patel from the Position of Whole Time Director as Well as Director of the Company	23-05-25	CI
Lincoln Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	23-05-25	CI
Lincoln Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-02-09	CI
Lincoln Pharmaceuticals Limited Informs About Demise of Shri Ishwarlal Ambalal Patel Independent Director	22-12-05	CI
Lincoln Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	22-11-10	CI
Lincoln Pharmaceuticals Limited Appoints Trusha Shah as Company Secretary and Compliance Officer	22-11-10	CI
Lincoln Pharmaceuticals Limited Approves to Declare Dividend for the Financial Year 2021-22	22-09-30	CI
Lincoln Pharmaceuticals Limited Proposes to Declare Dividend for the Financial Year 2021-2022	22-09-06	CI
Lincoln Pharmaceuticals Limited Approves Appointment of Anand A. Patel as an Additional and Whole Time Director	22-08-09	CI
Lincoln Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	22-08-09	CI
Lincoln Pharmaceuticals Limited Announces Resignation of Niren A. Desai as Company Secretary / Compliance Officer, with Effect from July 19, 2022	22-07-20	CI
Lincoln Pharmaceuticals : Newspaper Advertisements	22-05-20	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Lincoln Pharmaceuticals Limited NSE India S.E.

Equities

LINCOLN

INE405C01035

Summary

Filters